2013, American Heart Association
|
|
- Walter Riley
- 5 years ago
- Views:
Transcription
1 2013, American Heart Association
2 Mission: Lifeline - Data, Reports and ACTION Registry - GWTG THE MISSION: BETTER HEART ATTACK CARE FOR YOUR COMMUNITY THE LIFELINE: THE AMERICAN HEART ASSOCIATION AND YOU GAPS IN THE CARE SYSTEM COST LIVES - Each year, more than a hundred thousand ST-elevation myocardial infarction(stemi) patients fail to receive the best available treatment to restore blood flow to the heart muscle. - The American Heart Association created Mission: Lifeline as a response to missed opportunities caused by gaps in systems of care.
3 Presenters Lori Hollowell, BSN National Quality Systems Consultant Mission: Lifeline, ACTION Registry - GWTG American Heart Association Susan Rogers, BSN, MSN, NE-BC Director ACTION Registry - Get With The Guidelines American College of Cardiology Kevin I Daniel, RN, CEN Cardiovascular Data Specialist Quality Improvement Northside Hospital System, Atlanta, GA Chris Bjerke, BSN, MBA National Director- Mission: Lifeline American Heart Association 1/17/ , American Heart Association 3
4 Outline HOW TO USE ACTION REGISTRY- GWTG FOR QUALITY IMPROVEMENT I. ACTION Registry- GWTG Dashboard Reports: i. High profile data elements ii. Removing obstacles & improving outcomes II. Data output from the Premier versus Limited forms III. Using Mission: Lifeline Reports to Improve Outcomes i. Receiving Center / Regional Report Tools ii. Common questions on report interpretation III. Demonstration of data extract process IV. Multidisciplinary quality improvement: i. What disciplines are included in this team? ii. How often do you meet? V. How are the reports used to improve quality within your multidisciplinary team? What about improving quality within your system? VI. Are there data measures that are more frequent barriers to quality improvement? 1/17/ , American Heart Association 4
5 ACTION Registry -GWTG January 2013
6 Purpose of ACTION Registry-GWTG National surveillance system for high-risk AMI patients admitted with STEMI/NSTEMI: Assess characteristics, treatments, and outcomes of this patient population Optimize outcomes and management of AMI patients through implementation of ACC/AHA evidence-based guideline recommendations in clinical practice Facilitate efforts to improve quality and safety of ACS patient care; and investigate QI methods
7 Inclusion Population Acute Myocardial Infarctions-STEMI & NSTEMI only Patient must present to 1 st Facility with symptoms of ACS, within 24 hours of arrival Patient must have positive ECG- ST elevation, new LBBB, or documented Posterior MI OR Positive Biomarkers- Troponin or CK-MB Transfer In patients- STEMI must arrive within 72 hours, NSTEMI within 24 hours If the patient presents with any other symptoms, or procedures, the patient is excluded
8 Performance Measures Acute/In-hospital Measures Aspirin Arrival STEMI - Any reperfusion (PCI or Lytic) STEMI - Lytic -Door to Needle (Median Time and % <30min) STEMI - PCI D2B (Median Time and % <90min STEMI - D2B Transfer in (Median Time) LVSD Evaluation Discharge Measures Aspirin B-blocker ACE or ARB (EF <40%) Statin for LDL 100mg/dL Smoking cessation (among smokers) Cardiac rehabilitation
9 Door to EKG (within 10 min) Quality Metrics STEMI- Acute ADP Receptor Inhibitor Therapy Vascularized Patients Discharged on ADP Receptor Inhibitors ADP Receptor Inhibitors Prescribed at Discharge for medically treated patients LDL assessment (in-hospital) NSTEMI - Excessive Initial UFH Dosing (>70 U/kg bolus, >15 U/kg/min infusion) Excessive Initial Enoxaparin Dosing Excessive Initial GP IIb/IIIa Dosing STEMI - Anticoagulant- UFH, enoxaparin, bivalarudin or fondaparinux Aldosterone Blocking Agents at Discharge
10
11 ACTION Registry-GWTG Limited 50% of full AR-G data set Limited quarterly Outcome Report for benchmarking Report on 17 Core Performance Measures Report on 7 Quality Metrics
12 What the Limited form does not give you Quality Metrics not included 1. NSTEMI - Excessive Initial UFH Dosing (>70 U/kg bolus, >15 U/kg/min infusion 2. Excessive Initial Enoxaparin Dosing (SQ >1.05 mg/kg) 3. Excessive Initial GP IIb/IIIa Dosing (Full dose Tirofiban if CrCl<30& Full dose Eptifibatide CrCl <50, or dialysis with either) 4. STEMI - Anticoagulant- UFH, enoxaparin, bivalarudin or fondaparinux (first 24 hours)
13 Comprehensive Outcome Reports Comparison Groups Quarterly Real Time reports Benchmarks Performance measures & metrics Hospital experience Like facility National experience Registry Dashboard Drill Downs Unique compare groups ACTION Registry-GWTG 2012
14 How Does The Dashboard Work? Dashboard ereports Comparator ereports Standard Reports Executive Summary Metrics Drill Downs Comparator Define peer groups Facility attribute filters
15 Look How We Compare! Select Filter Criteria Run Analysis Compare / View Trends
16 H_7KYi Filter Criteria
17 Comparator analysis My Hospital R4Q 6 Quarter Trend
18 Mission: Lifeline Reports 1/17/ , American Heart Association 18
19 Companion Guides Mission: Lifeline Regional Hospital Report Glossary Mission: Lifeline Regional Hospital Report Interpretation Manual 1/17/ AHA Mission: Lifeline 19
20 Collect and Report Your Data 1/17/ AHA Mission: Lifeline 20
21 Mission: Lifeline Regional Reports Current Regional Reports - 18 Regional Reports Unique Hospitals Participating A group of hospitals looking at data from a regional perspective to improve the STEMI System of Care 1/17/ AHA Mission: Lifeline 21
22 What is the difference between a dash ( - ) and a 0%? A hyphen (-) Indicates no patient opportunities for that particular line item Will not adversely affect recognition efforts A 0% means there were patients eligible and no patients met the criteria for that line item May adversely affect recognition efforts 1/17/ AHA Mission: Lifeline 22
23 Records with Null values are included in the denominator in the Mission: Lifeline reports. 10 STEMI Patients are entered for Q All 10 are eligible to receive acute ASA (Seq ) All 10 patients were actually given ASA within first 24 hours of admission Per data entry, 7 of these 10 = Acute ASA = YES 3 of these patients have NO value entered was left blank Performance Score Reflected for Acute ASA: 70% 7 Documented as Administered / 10 Eligible 70% - Not Eligible for Mission: Lifeline Recognition 1/17/ AHA Mission: Lifeline 23
24 Why is our hospital is missing some data in the Mission: Lifeline report? Highlighted Area = Elements NOT available in the Limited Form Mission: Lifeline Receiving Hospital Report Glossary 1/17/ AHA Mission: Lifeline 24
25 Limited Form v Premier Form Data Limited Users Premier Users 25
26 The Limited form does not allow a primary reason to support why a patient is not a reperfusion candidate AR-G Premier Form Highlights Not included in Limited Form Mission: Lifeline Report Adjustments When 8000 = NO Patient record is EXCLUDED For BOTH Limited and Premier Form Users 1/17/ AHA Mission: Lifeline 26
27 Mission: Lifeline Reperfusion Therapy Measure score differs between the 2 reports (M:L and Outcomes) Mission: Lifeline uses Seq 7109 to identify primary PCI patients 1/17/ AHA Mission: Lifeline 27
28 First Medical Contact Mission: Lifeline Measure: Mission: Lifeline First Medical Contact to Primary PCI 90 Minutes Variable (%) All STEMI admissions who receive a primary PCI within 90 minutes from first medical contact prior to arrival at the Receiving Center. Pre-Arrival 1 st Med Contact Date/Time = Eye to Eye contact between the STEMI patient and the 1 st Medical provider to deliver (ACS) Acute Coronary Syndrome care 12 Lead ECG Aspirin Administration Nitroglycerine Administration 1/17/ AHA Mission: Lifeline 28
29 First Medical Contact to PCI < 90 Minutes Measure What patients are included? 1/17/ AHA Mission: Lifeline 29
30 First Medical Contact to PCI < 90 Minutes Measure: What patients are NOT included? 1/17/ AHA Mission: Lifeline 30
31 2013 Mission: Lifeline Recognition FEBRUARY th Q Data Deadline DQR = Green 2012 data updates for Q1,2,and 3 1/17/ AHA Mission: Lifeline 31
32 1/17/ , American Heart Association 32
33
34 Can you tell us how you have been able to partner with your EMS agencies?
35
36 FirstFacMeansTrans FirstMedConTi StemiNot me FirstECGObtained FirstECGTime ed ECGFindings ASA_First24Start FirstDevActiTi Time me PCIDelayReason ICD9PrinDiag Ambulance 2:26:00 After First Hospital Arrival 3:12:00 No 4:35:00 14:20:00 Ambulance 15:47:00 After First Hospital Arrival 18:26:00 No 20:40:00 Lumpkin Ambulance 6:31:00 After First Hospital Arrival 6:31:00 Yes ST Elevation 6:39:00 Ambulance 9:20:00 After First Hospital Arrival 9:59:00 Yes ST Elevation 15:38:00 10:42:00 None Advanced Ambulance 0:13:00 After First Hospital Arrival 0:34:00 Yes ST Elevation 0:35:00 1:13:00 None Advanced Ambulance 12:57:00 After First Hospital Arrival 13:26:00 No 13:45:00 Advanced Ambulance 2:11:00 Pre-Hospital 2:26:00 No 2:15:00 12:09:00 Lumpkin Ambulance 3:20:00 Pre-Hospital 3:28:00 Yes ST Elevation 3:24:00 5:05:00 None Ambulance 2:54:00 Pre-Hospital 3:19:00 Yes ST Elevation 3:05:00 4:50:00 None Ambulance 22:02:00 Pre-Hospital 22:15:00 Yes ST Elevation 22:17:00 23:29:00 None Ambulance 13:55:00 Pre-Hospital 14:11:00 Yes ST Elevation 14:08:00 15:27:00 None Ambulance 20:22:00 Pre-Hospital 20:35:00 Yes ST Elevation 21:20:00 21:31:00 None Forsyth Ambulance 0:18:00 Pre-Hospital 0:29:00 Yes ST Elevation 0:29:00 1:51:00 None Dawson Ambulance 7:55:00 Pre-Hospital 8:05:00 Yes ST Elevation 8:05:00 9:07:00 None Advanced Ambulance 14:36:00 Pre-Hospital 14:36:00 Yes ST Elevation 14:40:00 15:14:00 None Advanced Ambulance 20:44:00 Pre-Hospital 20:59:00 No 20:49:00 Ambulance 16:37:00 Pre-Hospital 16:47:00 No 16:49:00 Advanced
37
38 How do you use the dashboard reports to provide real-time feedback? Can you explain how you use the sort function? How do you address data entry errors once they are identified?
39 STEMI/ NSTEMI Aspirin Evaluation of LV Reperfusion Systolic Function Therapy (STEMI only) Time to Primary PCI (STEMI only) Aspirin at Beta Blocker Discharge at Discharge ACE-I or ARB for LVSD at Discharge Statin at Discharge Adult Smoking Cessation Advice Cardiac Rehab Referral STEMI Yes Yes Yes Yes Yes Yes Yes Yes Yes STEMI Yes Yes Yes STEMI Yes Yes Yes Yes Yes Yes STEMI No Yes STEMI Yes Yes Yes Yes Yes Yes Yes Yes Yes STEMI Yes Yes Yes Yes Yes Yes Yes STEMI Yes Yes Yes Yes Yes Yes Yes Yes STEMI Yes Yes Yes Yes Yes Yes Yes Yes Yes STEMI Yes Yes Yes Yes Yes Yes STEMI Yes Yes Yes No Yes Yes Yes Yes
40 Are there any data measures that are barriers to quality Improvement?
41 FirstFacMeansTrans FirstMedConTime OnsetTime FirstECGObtained StemiNoted Physician1 Physician2 Ambulance 9:20:00 7:00:00 After First Hospital Arrival Yes Smith Self/Family 2:55:00 After First Hospital Arrival Yes Smith Ambulance 0:18:00 22:52:00 Pre-Hospital Yes Jones Ambulance 0:13:00 21:32:00 After First Hospital Arrival Yes Miller Adams Self/Family 18:23:00 After First Hospital Arrival Yes Adams Ambulance 7:55:00 7:23:00 Pre-Hospital Yes Miller Ambulance 14:36:00 13:50:00 Pre-Hospital Yes Jones Self/Family 7:00:00 After First Hospital Arrival Yes Jones Self/Family 10:45:00 After First Hospital Arrival Yes Smith Jones Self/Family 10:45:00 After First Hospital Arrival No Miller Ambulance 12:57:00 14:20:00 After First Hospital Arrival No Adams Ambulance 20:44:00 20:24:00 Pre-Hospital No Adams Self/Family 12:25:00 After First Hospital Arrival No Miller Adams Self/Family 18:54:00 After First Hospital Arrival No Jones Self/Family 2:30:00 After First Hospital Arrival No Adams Jones Self/Family 12:35:00 After First Hospital Arrival No Miller Ambulance 16:37:00 16:12:00 Pre-Hospital No Miller Self/Family 22:40:00 After First Hospital Arrival Yes Smith
42 Additional Questions? 1/17/ , American Heart Association 42
Dashboard and Outcomes Report with Case Studies
Dashboard and Outcomes Report with Case Studies Kim Hustler Clinical Quality Consultant, American College of Cardiology The following relationships exist: Kim Hustler: No Disclosures Section F- Procedures
More informationInstitutional Outcomes Report 2012Q2 Sample Hospital
Version 2.2 Institutional Outcomes Report 2012Q2 If User desires to publish or otherwise distribute or use, in whole or in part, any aggregate data or reports provided by ACCF, or produced in connection
More informationData Elements and Definitions with Case Studies. Interpreting Your Outcomes Reports. Kim Hustler, Clinical Quality Consultant, NCDR
Data Elements and Definitions with Case Studies Interpreting Your Outcomes Reports Kim Hustler, Clinical Quality Consultant, NCDR Beth Pruski, Program Manager, NCDR The following relationships exist: Beth
More informationGET WITH THE GUIDELINES- PAST AND FUTURE
GET WITH THE GUIDELINES- PAST AND FUTURE Amy Graham, RN, BS, CEN, NREMT-P Director, Quality & Systems Improvement Kentucky and Southwest Ohio American Heart Association 1 DISCLOSURE SLIDE I AM THE QUALITY
More informationKnow the Quality of our Care at Every Step. Kansas City ACS Summit BI-State Cardiovascular Education Consortium
Know the Quality of our Care at Every Step Kansas City ACS Summit BI-State Cardiovascular Education Consortium Welcome to the Kansas City ACS Summit Objectives: Follow the flow and care of an ACS patient
More information4. Which survey program does your facility use to get your program designated by the state?
STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI
More informationPatient Navigator Program: Focus MI Diplomat Hospital Metrics
Patient Navigator Program: Focus MI Diplomat Hospital Metrics Goal Statement: To reduce avoidable hospital readmissions for patients discharged with acute myocardial infarction (AMI) by supporting a culture
More information2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction Ramzi Khalil MD FACC Assistant Professor Allegheny Gen.Hospital AHN Speakers
More informationAcute Coronary Syndrome (ACS) Initial Evaluation and Management
Acute Coronary Syndrome (ACS) Initial Evaluation and Management Symptoms of Possible ACS Chest discomfort with or without radiation to the arm(s), jaw, or epigastrium Short of breath Weakness Diaphoresis
More informationAcute Coronary Syndromes
Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management
More informationGWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival
GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION Page 1 Legend: BOLD = Required ^ = MLL Data Element Admin (Tab) ^Patient ID: Physician/Provider NPI: DOB: / / ^Arrival Date/Time: Race: Hispanic
More information1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11
May 2011 1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11 Yes b) If confirmed please provide details on the number of
More informationSanford Chest Pain Network: Improving Rural STEMI Outcomes
Sanford Chest Pain Network: Improving Rural STEMI Outcomes Naveen Rajpurohit, MD Cardiovascular Fellow Sanford Cardiovascular Institute Sanford Heart Hospital The University of South Dakota Sioux Falls,
More informationDaily practice of ACS management in the Gulf: Data from Gulf COAST
Daily practice of ACS management in the Gulf: Data from Gulf COAST Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Head, Division of Cardiology Mubarak Alkabeer Hospital
More informationACTION Registry GWTG Research and Publications Update
ACTION Registry GWTG Research and Publications Update Dr. Michael Kontos Director, Coronary Intensive Care Unit Pauley Heart Center, Virginia Commonwealth University The following relationships exist:
More information2012 Core Measures. Acute Myocardial Infarction (AMI)
2012 Core Measures Acute Myocardial Infarction (AMI) Aspirin at Arrival Aspirin Prescribed at Discharge Angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) for left ventricular
More informationPractice-Level Executive Summary Report
PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular
More informationMeasurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for Artery, Atrial Fibrillation, Hypertension
More informationAcute coronary syndromes (ACS), including unstable
n report n Acute Coronary Syndromes: Morbidity, Mortality, and Pharmacoeconomic Burden Daniel M. Kolansky, MD Abstract Acute coronary syndromes (ACS), which include unstable angina and myocardial infarction
More informationNEW JERSEY 2011 HOSPITAL PERFORMANCE REPORT TECHNICAL REPORT: METHODOLOGY RECOMMENDED CARE (PROCESS OF CARE) MEASURES
NEW JERSEY 2011 HOSPITAL PERFORMANCE REPORT TECHNICAL REPORT: METHODOLOGY RECOMMENDED CARE (PROCESS OF CARE) MEASURES New Jersey Department of Health and Senior Services Health Care Quality Assessment
More informationQ1 Contact Information
Q1 Contact Information Answered: 25 Skipped: 0 ANSWER CHOICES Hospital Name of Person Completing Survey Email RESPONSES 100.00% 25 100.00% 25 100.00% 25 # HOSPITAL DATE 1 Research Medical Center 9/26/2018
More informationEMS Recognition Webinar August 24, 2017
EMS Recognition Webinar August 24, 2017 Today s objectives: Provide you with some rationale regarding the importance of reducing FMC to device time Provide you with an overview of the 2017 Mission: Lifeline
More informationVersion 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM
Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute
More informationNHS QIS National Measurement of Audit Acute Coronary Syndrome
NHS QIS National Measurement of Audit Acute Coronary Syndrome Things have changed based on the experience and feedback from the first cycle of measurement and, for the better we think! The Acute Coronary
More informationTransfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem
Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927
More informationProgram Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.
More informationNEW JERSEY 2012 HOSPITAL PERFORMANCE REPORT TECHNICAL REPORT: METHODOLOGY RECOMMENDED CARE (PROCESS OF CARE) MEASURES
NEW JERSEY 2012 HOSPITAL PERFORMANCE REPORT TECHNICAL REPORT: METHODOLOGY RECOMMENDED CARE (PROCESS OF CARE) MEASURES New Jersey Department of Health Health Care Quality Assessment June 2013 NEW JERSEY
More informationMission: Lifeline Addressing the System of STEMI Care
Mission: Lifeline Addressing the System of STEMI Care Alice K. Jacobs, M.D. Boston University Medical Center Boston, MA, USA ACC West Virginia Chapter, April 2017 Disclosure Information FINANCIAL DISCLOSURE:
More informationManaging Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics
Managing Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics Robert L. Jesse, MD, PhD National Program Director for Cardiology Veterans Health Administration Washington, DC Chief, Cardiology
More information2010 ACLS Guidelines. Primary goals of therapy for patients
2010 ACLS Guidelines Part 10: Acute Coronary Syndrome Present : 內科 R1 鍾伯欣 Supervisor: F1 吳亮廷 991110 Primary goals of therapy for patients of ACS Reduce the amount of myocardial necrosis that occurs in
More informationREFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO
REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Jean Skonhovd,RN,BSN,MSAS Emergency Department Director Avera Heart Hospital of South Dakota Time to Treatment is critical for STEMI patients
More informationThe Evolving ACC-NCDR Programs: What you need to know for your practice
The Evolving ACC-NCDR Programs: What you need to know for your practice John S. Rumsfeld, MD PhD FACC Chief Science Officer and Chair, American College of Cardiology National Cardiovascular Data Registry
More informationRural Minnesota STEMI Systems of Care
CARDIOVASCULAR HEALTH UNIT Rural Minnesota STEMI Systems of Care Almost 250,000 Americans experience ST-elevation Myocardial Infarction (STEMI), the deadliest form of heart attack, each year. Of approximately
More informationST-elevation myocardial infarctions (STEMIs)
Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve
More informationNEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association
NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki 2013, American Heart Association 1 Dr. Doug Kosmicki Reperfusion Strategies Disclosure Information Report any disclosure information of conflicts of interest.
More informationUCLA Health System Apr - Jun 2013 (Q2)
Denom Observed VBP Standard VBP Benchmark Denom Observed VBP Standard VBP Benchmark N Percent x/n N Percent x/n Value Based Purchasing-Clinical Process of Care Measures (%) SCIP-Inf-9 Urinary catheter
More informationDISCUSSION QUESTION - 1
CASE PRESENTATION 87 year old male No past history of diabetes, HTN, dyslipidemia or smoking Very active Medications: omeprazole for heart burn Admitted because of increasing retrosternal chest pressure
More informationGet With The Guidelines: Lessons for National Healthcare Improvement Programs
Get With The Guidelines: Lessons for National Healthcare Improvement Programs Gregg C. Fonarow, MD, FACC, FAHA, FHFSA Eliot Corday Professor of Cardiovascular Medicine and Science UCLA Division of Cardiology
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationCindy Stephens, MSN, ANP Kelly Walker, MS, ACNP Peter Cohn, MD, FACC
Cindy Stephens, MSN, ANP Kelly Walker, MS, ACNP Peter Cohn, MD, FACC Define Acute Coronary syndromes Explain the Cause Assessment, diagnosis and therapy Reperfusion for STEMI Complications to look for
More informationContinuing Medical Education Post-Test
Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on
More informationMedical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the
More informationAn update on the management of UA / NSTEMI. Michael H. Crawford, MD
An update on the management of UA / NSTEMI Michael H. Crawford, MD New ACC/AHA Guidelines 2007 What s s new in the last 5 years CT imaging advances Ascendancy of troponin and BNP Clarification of ACEI/ARB
More informationProtocols for the Management of Cardiac Conditions. By Pam Bayles, RN, BSN
Protocols for the Management of Cardiac Conditions By Pam Bayles, RN, BSN Deaths in Thousands 1,000 800 600 400 200 0 00 10 20 30 40 50 60 70 80 90 00 06 Years Deaths from diseases of the heart (United
More informationconvey the clinical quality measure's title, number, owner/developer and contact
CMS-0033-P 153 convey the clinical quality measure's title, number, owner/developer and contact information, and a link to existing electronic specifications where applicable. TABLE 20: Proposed Clinical
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationSUNY Downstate Medical Center/University Hospital Oct - Dec 2013 (Q4)
Value Based Purchasing-Clinical Process of Care Measures Denom Observed VBP VBP Benchmark Standard Denom Observed VBP VBP Benchmark Standard N Percent x/n N Percent x/n SCIP-Inf-9 Urinary catheter removed
More informationManagement of Acute Myocardial Infarction
Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care
More informationAMI 100% 80% 60% 40% 20% AMI: Aspirin at Arrival Targets AMI: Aspirin at D/C 2 - Aspirin at Discharge: Targets 100% 80% 60% 40% 20%
AMI AMI: 1 - Aspirin at Arrival AMI: 2 - Aspirin at Discharge AMI: Aspirin at Arrival Targets AMI: Aspirin at D/C 2 - Aspirin at Discharge: Targets AMI: 3 - ACEI or ARB for LVSD AMI: 4 - Adult Smoking
More informationUpdates to Advanced Certification for Primary Stroke Centers and Advanced Certification in Heart Failure
Updates to Advanced Certification for Primary Stroke Centers and Advanced Certification in Heart Failure February 9, 2012 1 New Features of The Joint Commission / American Heart Association / American
More informationAppendix: ACC/AHA and ESC practice guidelines
Appendix: ACC/AHA and ESC practice guidelines Definitions for guideline recommendations and level of evidence Recommendation Class I Class IIa Class IIb Class III Level of evidence Level A Level B Level
More informationIdentification and pre-notification using 12-Lead. Why this so important to our STEMI System
Identification and pre-notification using 12-Lead Why this so important to our STEMI System Jim Smith, MD Great Plains Health, North Platte Chair, NE State EMS Board Medical Director, Emergency Services,
More informationUpdate on Antithrombotic Therapy in Acute Coronary Syndrome
Update on Antithrombotic Therapy in Acute Coronary Syndrome Laura Tsang November 13, 2006 Objectives: By the end of this session, you should understand: The role of antithrombotics in ACS Their mechanisms
More informationPerformance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set
Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer
More informationSTEMI, Non-STEMI, Chest Pain?
Minnesota Chest Pain / Acute Coronary Syndrome Tool-Kit Patient with Chest Pain Or Potential Acute Coronary Syndrome STEMI, n-stemi, Chest Pain? Follow MN STEMI Guideline Follow MN n-stemi Guideline Follow
More informationAcute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
More informationClinical Case. Management of ACS Based on ACC/AHA & ESC Guidelines. Clinical Case 4/22/12. UA/NSTEMI: Definition
Clinical Case Management of ACS Based on ACC/AHA & ESC Guidelines Dr Badri Paudel Mr M 75M Poorly controlled diabetic Smoker Presented on Sat 7pm Intense burning in the retrosternal area Clinical Case
More informationTreatment of Acute Coronary Syndromes
Treatment of Acute Coronary Syndromes UC SF Jeffrey Tabas, M.D. sf g h Associate Professor UCSF School of Medicine Emergency Services, San Francisco General Hospital Objectives Review the updated AHA/ACC
More informationST Elevation Myocardial Infarction
ST Elevation Myocardial Infarction Scott M. Lilly, MD, PhD Assistant Professor Clinical Department of Cardiovascular Medicine The Ohio State University Wexner Medical Center Case Presentation 46 year old
More informationVHA Performance Measurement In Cardiac Care
VHA Performance Measurement In Cardiac Care A Map for VHA Cardiac Performance Measurement in FY 2005 and beyond Roxane Rusch, BSN, MPA, RN Department Of Veterans Affairs Office of Quality and Performance
More informationIt is not enough to do your best, you must know what to do and then do your best
Creating Effective Regional Stroke Systems of Care Stroke Strategies for Success Workshop October 3, 2012 Rick Foster, MD It is not enough to do your best, you must know what to do and then do your best
More informationMission: Lifeline EMS Recognition : FMC to Device < 90 Minutes Worksheet
Mission: Lifeline EMS Recognition : FMC to Device < 90 Minutes Worksheet Did Pt. Receive PCI FMC to PCI < 90 Minutes Exclusions Documented Delay after hospital arrival (Refer to Page 4 in EMS Recognition
More information2/26/2013. NCDR.13 Case Scenario Presentation Cath PCI Registry. Disclosures. Objectives. Dashboard Implications of Some Major Metrics
NCDR.13 Case Scenario Presentation Cath PCI Registry Dashboard Implications of Some Major Metrics Disclosures Tony Hermann has nothing to disclose Mark Hutcheson has nothing to disclose Cornelia Anderson
More informationPharmaco-Invasive Approach for STEMI
Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),
More informationHEART FAILURE QUALITY IMPROVEMENT. American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement
HEART FAILURE QUALITY IMPROVEMENT American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement 1 DISCLOSURES NONE 2 3 WHY IS THIS IMPORTANT? WHY? Heart Failure Currently, an
More informationOVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS 9/30/14 TYPICAL WHAT IS ACUTE CORONARY SYNDROME? SYMPTOMS, IDENTIFICATION, MANAGEMENT
OVERVIEW ACUTE CORONARY SYNDROME SYMPTOMS, IDENTIFICATION, MANAGEMENT OCTOBER 7, 2014 PETE PERAUD, MD SYMPTOMS TYPICAL ATYPICAL IDENTIFICATION EKG CARDIAC BIOMARKERS STEMI VS NON-STEMI VS USA MANAGEMENT
More informationSCORES FOR 4 TH QUARTER, RD QUARTER, 2014
SCORES FOR 4 TH QUARTER, 2013 3 RD QUARTER, 2014 PATIENT SATISFACTION SCORES (HCAHPS): 4 STARS OUT OF 5 (ONLY 4 AREA ACUTE CARE HOSPITALS RECEIVED A 4-STAR RATING. NONE ACHIEVED 5-STARS). STRUCTURAL MEASURES:
More informationAcute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine
Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute
More informationOtamixaban for non-st-segment elevation acute coronary syndrome
Otamixaban for non-st-segment elevation acute coronary syndrome September 2011 This technology summary is based on information available at the time of research and a limited literature search. It is not
More informationST Elevation Myocardial Infarction
ST Elevation Myocardial Infarction Scott M. Lilly, MD, PhD Assistant Professor Clinical Department of Cardiovascular Medicine The Ohio State University Wexner Medical Center Outline Case Presentation STEMI
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Chung S-C, Gedeborg R, Nicholas O, et al. Acute
More informationQuality Payment Program: Cardiology Specialty Measure Set
Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for
More informationAcute Coronary Syndrome in Phrae Hospital
Acute Coronary Syndrome in Phrae Hospital Cardiovascular Unit, Department of Medicine, Phrae hospital, Phrae Thailand. Objective: To study the epidemiology, management and outcome of patients with acute
More informationQuality Payment Program: Cardiology Specialty Measure Set
Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor
More informationA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction 1
More informationCLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA
RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research
More informationHealthy People 2020 Summary of Objectives. Heart Disease and Stroke
Healthy People 2020 Summary of Objectives Heart Disease and Stroke Number HDS 1 HDS 2 HDS 3 HDS 4 HDS 5 HDS 6 HDS 7 HDS 8 HDS 9 HDS 10 HDS 11 HDS 12 HDS 13 HDS 14 HDS-15 HDS 16 HDS 17 HDS 18 HDS 19 HDS
More informationTreatment of ST-elevation myocardial infarction in China: Where are we?
Treatment of ST-elevation myocardial infarction in China: Where are we? Associate Professor, Yihong Sun, MD Peking University People s Hospital Beijing, China Disclosure conflict of Interest The Challenges
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More informationBeta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
More informationAcute Coronary Syndrome
Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with
More informationSHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION?
SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION? Doron Zahger, MD Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion
More informationQuality indicators for acute myocardial infarction: A position paper of the. Acute Cardiovascular Care Association
Manuscript (include Title page, Abstract and References) Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association Francois Schiele, MD, PhD; Chris
More information2018 Acute Coronary Syndrome. Robert Bender, DO, FACOI, FACC Central Maine Heart and Vascular Institute
2018 Acute Coronary Syndrome Robert Bender, DO, FACOI, FACC Central Maine Heart and Vascular Institute Definitions: Acute Myocardial Ischemia Unstable Angina Non-ST-Elevation MI (NSTEMI) }2/3 ST-Elevation
More informationPresenters: Disclaimer. Definitions. Deanna Jones, RN, CCRN. Annmarie Keck, RN, CEN
Presenters: Deanna Jones, RN, CCRN Cardiac Level 1 Coordinator, Providence Sacred Heart Medical Center and Children s Hospital, Spokane, WA Annmarie Keck, RN, CEN Clinical Outreach Educator Northwest MedStar,
More informationQuality Committee Core Measures Report AMI. Acute Myocardial Infarction
AMI 2011 Acute Myocardial Infarction ASPIRIN AT ARRIVAL: A higher number is better. This measure shows the percentage of heart attack patients who receive aspirin within 24 hrs of arrival at hospital.
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationObjectives 1/10/2013. Hospital Outpatient Quality Reporting Specifications Manual Updates January 1, 2013
Hospital Outpatient Quality Reporting Specifications Manual Updates January 1, 2013 Wanda Johnson, OFMQ Casey Thompson, OFMQ Kari Johnston, OFMQ Hospital Outpatient Quality Reporting Program Announcements
More informationAcute Coronary Syndrome. Emergency Department Updated Jan. 2017
Acute Coronary Syndrome Emergency Department Updated Jan. 2017 Goals and Objectives To reduce mortality and morbidity for people who have cardiovascular disease, with a focus on those who experience an
More informationGuideline for STEMI. Reperfusion at a PCI-Capable Hospital
MANSOURA. 2015 Guideline for STEMI Reperfusion at a PCI-Capable Hospital Mahmoud Yossof MANSOURA 2015 Reperfusion Therapy for Patients with STEMI *Patients with cardiogenic shock or severe heart failure
More informationTailoring adjunctive antithrombotic therapy to reperfusion strategy in STEMI
Tailoring adjunctive antithrombotic therapy to reperfusion strategy in STEMI Adel El-Etriby; MD Professor of Cardiology Ain Shams University President of the Egyptian Working Group of Interventional Cardiology
More informationIs it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention
Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention DA Jones, J Howard, S Gallagher, KS Rathod, A Jain, S Mohiddin, C Knight, A Mathur, EJ
More informationManagement of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police
Management of STEMI in era of Reperfusion Eagles 2007 Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police STEMI in US ST Segment Elevation Myocardial Infarction (STEMI) ~500 K per year Thrombolysis
More informationAcute Coronary Syndrome
Acute Coronary Syndrome Vik Gongidi, DO FACOI, FACC Indian River Medical Center Vero Beach, FL Slides adapted from Robert Bender, DO, FACOI, FACC Definition: Acute Myocardial Ischemia Unstable Angina Non-ST-Elevation
More informationThe Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium
The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications
More informationThe Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:
The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: Nathaniel Niles, MD CREST Symposium November 7th, 28 STEMI = Acute Coronary Thrombosis STEMI
More informationMarcin Dada, MD December 03, 2013
STEMI Imposters Marcin Dada, MD December 03, 2013 Marcin Dada, MD Associate Director, Chest Pain Center Hartford Hospital, Hartford, CT Member, AHA Mission Lifeline Steering Committee Outline of Topics
More informationConsensus Core Set: Cardiovascular Measures Version 1.0
Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized
More informationThe Role of Cardiac Rehabilitation in Recovery & Secondary Prevention. Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager
The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager Objectives Core Components of Cardiac Rehab Program CR Indications &
More informationUpdate on STEMI Guidelines. Manesh R. Patel, MD Assistant Professor of Medicine Duke University Medical Center
Update on STEMI Guidelines Manesh R. Patel, MD Assistant Professor of Medicine Duke University Medical Center All Rights Reserved, Duke Medicine 2008 Disclosures Research Grants: NHLB, AHRQ, AstraZeneca,
More information